Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Paul E Hanna"'
Autor:
Paul E. Hanna, Tianqi Ouyang, Ismail Tahir, Nurit Katz‐Agranov, Qiyu Wang, Lea Mantz, Ian Strohbehn, Daiana Moreno, Destiny Harden, James E. Dinulos, Duru Cosar, Harish Seethapathy, Justin F. Gainor, Sachin J. Shah, Shruti Gupta, David E. Leaf, Florian J. Fintelmann, Meghan E. Sise
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 3, Pp 1187-1198 (2024)
Abstract Background Creatinine‐based estimated glomerular filtration rate (eGFRCRE) may overestimate kidney function in patients with sarcopenia. While cystatin C‐based eGFR (eGFRCYS) is less affected by muscle mass, it may underestimate kidney f
Externí odkaz:
https://doaj.org/article/44af5f6f1ea54b2c8f09c7cb3eb582ac
Autor:
Paul E. Hanna, Ian A. Strohbehn, Daiana Moreno, Destiny Harden, Rituvanthikaa Seethapathy, Rani Sawtell, Qiyu Wang, Tianqi Ouyang, Nurit Katz-Agranov, James Dinulos, Seth A. Wander, Shruti Gupta, Meghan E. Sise
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-3 (2023)
Abstract Cyclin-dependent kinase (CDK) 4/6 inhibitors have significantly improved overall and progression free survival of patients with metastatic breast cancer, but their effect on short and long-term kidney function is unknown. We found that early
Externí odkaz:
https://doaj.org/article/bacda39a28c04f239fc576d7a9c65ac0
Autor:
Shruti Gupta, Paul E Hanna, Tianqi Ouyang, Karla Sofia Yamada, Rani Sawtell, Qiyu Wang, Nurit Katz-Agranov, Lea Feghali, Carolyn N Krasner, Sara Bouberhan, Cesar M Castro, Meghan E Sise
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the treatment of ovarian cancer; however, real-world data on kidney function among patients treated with PARPi are lacking. Methods We identified adults treated with olapa
Autor:
Juliana Vergara-Cadavid, P. Connor Johnson, Haesook T. Kim, Alisha Yi, Meghan E. Sise, David E. Leaf, Paul E. Hanna, Vincent T. Ho, Corey S. Cutler, Joseph H. Antin, Mahasweta Gooptu, Amar H. Kelkar, Sophia L. Wells, Sarah Nikiforow, John Koreth, Rizwan Romee, Robert J. Soiffer, Roman M. Shapiro, Shruti Gupta
Publikováno v:
Transplantation and Cellular Therapy.
Autor:
Wonkyung J Cho, Destiny Harden, Daiana Moreno, James E Dinulos, Paul E Hanna, Qiyu Wang, Arthur Y Kim, Meghan E Sise
Publikováno v:
Nephrology Dialysis Transplantation.
Autor:
Paul E. Hanna, Tianqi Ouyang, Ismail Tahir, Nurit Katz-Agranov, Qiyu Wang, Lea Mantz, Ian Strohbehn, Daiana Moreno, Destiny Harden, James E. Dinulos, Duru Cosar, Harish Seethapathy, Justin F. Gainor, Sachin J. Shah, Shruti Gupta, David E. Leaf, Florian J. Fintelman, Meghan E. Sise
PurposeCreatinine-based estimated glomerular filtration rate (eGFRCRE) may overestimate kidney function in patients with sarcopenia. While Cystatin C-based eGFR (eGFRCYS) is less affected by muscle mass, it may underestimate kidney function in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4235ccc18427ce5c9daba14368dd24d7
https://doi.org/10.1101/2023.02.08.23285587
https://doi.org/10.1101/2023.02.08.23285587
Autor:
Paul E. Hanna, Qiyu Wang, Ian Strohbehn, Daiana Moreno, Destiny Harden, Tianqi Ouyang, Nurit Katz-Agranov, Harish Seethapathy, Kerry L. Reynolds, Shruti Gupta, David E. Leaf, Meghan E. Sise
Publikováno v:
medRxiv
BackgroundCreatinine-based estimated glomerular filtration rate (eGFRCRE) may overestimate kidney function in patients with cancer. Cystatin C-based eGFR (eGFRCYS) is an alternative marker of kidney function. We investigated whether patients with an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f229a5633ab16ff20ed9c810144ce59c
https://doi.org/10.1101/2023.01.18.23284656
https://doi.org/10.1101/2023.01.18.23284656
Autor:
Shruti Gupta, Ian A. Strohbehn, Qiyu Wang, Paul E. Hanna, Rituvanthikaa Seethapathy, Jason M. Prosek, Sandra M. Herrmann, Ala Abudayyeh, A. Bilal Malik, Sebastian Loew, Christopher A. Carlos, Wei-Ting Chang, Pazit Beckerman, Zain Mithani, Chintan V. Shah, Amanda D. Renaghan, Sophie de Seigneux, Luca Campedel, Abhijat Kitchlu, Daniel Sanghoon Shin, Gaia Coppock, Nuttha Lumlertgul, Pablo Garcia, David I. Ortiz-Melo, Arash Rashidi, Ben Sprangers, Vikram Aggarwal, Karolina Benesova, Kenar D. Jhaveri, Frank B. Cortazar, Astrid Weins, Yiqin Zuo, Meghan J. Mooradian, Kerry L. Reynolds, David E. Leaf, Meghan E. Sise, Joe-Elie Salem, Corinne Isnard Bagnis, Harkarandeep Singh, Shveta S. Motwani, Naoka Murakami, Maria C. Tio, Suraj S. Mothi, Umut Selamet, Kai M. Schmidt-Ott, Weiting Chang, Rimda Wanchoo, Yuriy Khanin, Jamie S. Hirsch, Vipulbhai Sakhiya, Daniel Stalbow, Sylvia Wu, Marlies Ostermann, Nina Seylanova, Armando Cennamo, Anne Rigg, Nisha Shaunak, Zoe A. Kibbelaar, Priya Deshpande, Harish S. Seethapathy, Meghan Lee, Ian A. Strohbhen, Busra Isik, Ilya G. Glezerman, Sunandana Chandra, Sethu M. Madhavan, Dwight H. Owen, Marium Husain, Sharon Mini, Shuchi Anand, Aydin Kaghazchi, Sunil Rangarajan, Grace Cherry, Raymond K. Hsu, Andrey Kisel, Sheru K. Kansal, Nicole Albert, Katherine Carter, Vicki Donley, Tricia Young, Heather Cigoi, Sophie De Seigneux, Thibaud Koessler, Els Wauters, Mark Eijgelsheim, Javier A. Pagan, Jonathan J. Hogan, Omar Mamlouk, Jamie S. Lin, Valda Page, Samuel A.P. Short, Elizabeth M. Gaughan, Maria Jose Soler, Clara García-Carro, Sheila Bermejo, Enriqueta Felip, Eva Muñoz-Couselo, Maria Josep Carreras
Publikováno v:
Kidney international. 102(4)
Publikováno v:
Journal of Onco-Nephrology. :239936932211503
Oxaliplatin, a platinum-based compound, is the standard cancer therapy for treatment of metastatic colorectal carcinoma and other gastrointestinal malignancies. Oxaliplatin-induced nephrotoxicities include acute kidney injury due to acute tubular inj
Publikováno v:
Journal of the American Veterinary Medical Association. 257(2)